JAKARTA – PT Cipta Sarana Medika Tbk (DKHH) has announced plans for its initial public offering (IPO) on the Indonesia Stock Exchange, by issuing 530 million shares with a nominal value of IDR 50 per share.

According to the IPO prospectus, the shares offered to the public represent 20.78% of the company’s issued and paid-up capital.

DKHH has set an offering price ranging from IDR 100 to IDR 132 per share, meaning the company could raise up to IDR 69.96 billion from the IPO.

In addition to offering shares, DKHH will also provide a bonus of 265 million series I warrants, at a ratio of 2:1, meaning every two new shares purchased will entitle the holder to one series I warrant. These warrants can later be exercised to purchase one new share.

DKHH is the issuer managing the DKH hospital network. According to its official website, DKHH currently operates three hospital units in Cibadak, Sukabumi; Kedungwaringin, Bekasi; and Sukatani, Bekasi.

According to the IPO prospectus, around 64.3% of the IPO proceeds will be used for renovation, expansion, and upgrading facilities at DKH Cibadak Hospital, while the remainder will be allocated for marketing expenses and vendor payments.

Supported by PT MNC Sekuritas as the underwriter, the bookbuilding period for DKHH runs from 24–28 April 2025, with the public offering projected to take place from 5–8 May, and listing on the IDX scheduled for 14 May 2025. (ZH)